Mechanistically, this latter study demonstrates that the PAX5 transcription factor transactivates Prostaglandin-Endoperoxide Synthase-2 gene transcription, which promotes bladder cancer pathogenic features [95]. The gene discussed is PAX5; the disease is urinary bladder carcinoma.